Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins
- PMID: 8380079
- PMCID: PMC237365
- DOI: 10.1128/JVI.67.1.315-322.1993
Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins
Abstract
Vaccinia virus vectors were used to express the major (L1) and minor (L2) capsid proteins of human papillomavirus type 1 (HPV-1) with the vaccinia virus early (p7.5K) or late (pSynth, p11K) promoters. All constructs expressed the appropriate-sized HPV proteins, and both L1 and L2, singly or in combination, localized to the nucleus. Capsids were purified by cesium chloride density gradient centrifugation from nuclei of cells infected with a vaccinia virus-L1 (vac-L1) recombinant or a vac-L1-L2 recombinant but not from vac-L2-infected cells. Electron microscopy showed that the particles were 55 nm in diameter and had icosahedral symmetry. Immunogold-labeled antibodies confirmed the presence of the L1 and L2 proteins in the HPV-1 capsids. Capsids containing L1 alone were fewer and more variable in size and shape than capsids containing the L1 and L2 proteins. The L1-plus-L2 capsids were indistinguishable in appearance from HPV-1 virions obtained from plantar warts. The ability to produce HPV capsids in vitro will be useful in many studies of HPV pathogenicity.
Similar articles
-
Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells.Virology. 1994 May 1;200(2):504-12. doi: 10.1006/viro.1994.1213. Virology. 1994. PMID: 8178438
-
Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.Virology. 1991 Nov;185(1):251-7. doi: 10.1016/0042-6822(91)90772-4. Virology. 1991. PMID: 1656586
-
Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.Virology. 1995 Dec 20;214(2):349-59. doi: 10.1006/viro.1995.0044. Virology. 1995. PMID: 8553535
-
L2, the minor capsid protein of papillomavirus.Virology. 2013 Oct;445(1-2):175-86. doi: 10.1016/j.virol.2013.04.017. Epub 2013 May 17. Virology. 2013. PMID: 23689062 Free PMC article. Review.
-
Insights into the role and function of L2, the minor capsid protein of papillomaviruses.Arch Virol. 2009;154(2):187-97. doi: 10.1007/s00705-009-0310-3. Epub 2009 Jan 25. Arch Virol. 2009. PMID: 19169853 Review.
Cited by
-
Nanotherapeutics for treating coronavirus diseases.J Drug Deliv Sci Technol. 2021 Aug;64:102634. doi: 10.1016/j.jddst.2021.102634. Epub 2021 Jun 10. J Drug Deliv Sci Technol. 2021. PMID: 34127930 Free PMC article. Review.
-
Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.J Virol. 2010 Feb;84(4):1967-76. doi: 10.1128/JVI.01840-09. Epub 2009 Dec 9. J Virol. 2010. PMID: 20007267 Free PMC article.
-
Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide.mBio. 2019 Aug 6;10(4):e01834-19. doi: 10.1128/mBio.01834-19. mBio. 2019. PMID: 31387913 Free PMC article.
-
White blood cell image analysis for infection detection based on virtual hexagonal trellis (VHT) by using deep learning.Sci Rep. 2023 Oct 19;13(1):17827. doi: 10.1038/s41598-023-44352-8. Sci Rep. 2023. PMID: 37857667 Free PMC article.
-
Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments.J Virol. 1995 Dec;69(12):7743-53. doi: 10.1128/JVI.69.12.7743-7753.1995. J Virol. 1995. PMID: 7494284 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical